Chinese researchers have found that recovered COVID-19 patients still harbor some immune cells that can fend off the virus at least two years after the initial infection, but updated vaccination is essential in boosting immunization against emerging variants.
China will likely see simultaneous circulations of multiple respiratory illnesses, including COVID-19, influenza and mycoplasma pneumoniae infections, this winter and spring, the Joint Prevention and Control Mechanism of State Council said in a circular released on 24th of Nov.
Despite rising numbers of people on social media claiming to have been infected with COVID-19 for a third time recently, experts have said that those reinfected most likely only had mild symptoms.
Although COVID-19 infections in some regions have increased slightly and travel during the upcoming May Day holiday is expected to boom, the possibility of large-scale outbreaks occurring in the short term remains small.
In the wake of COVID-19 being managed as a Class B infectious disease, Beijing will establish a new scientific monitoring and warning system for its epidemic control and prevention, a senior official in the capital said on Monday.